loadpatents
Patent applications and USPTO patent grants for Bates; Susan E..The latest application filed is for "non-hydrolyzable non-cleavable, stable linkers for precision therapeutics and uses thereof".
Patent | Date |
---|---|
Non-hydrolyzable Non-cleavable, Stable Linkers For Precision Therapeutics And Uses Thereof App 20220251143 - Fojo; Antonio Tito ;   et al. | 2022-08-11 |
Method of inhibiting ABCG2 and related treatments Grant 9,937,217 - Henrich , et al. April 10, 2 | 2018-04-10 |
Method of inhibiting ABCG2 and other treatment methods Grant 9,314,448 - Henrich , et al. April 19, 2 | 2016-04-19 |
Deacetylase inhibitor therapy Grant 9,259,452 - McCulloch , et al. February 16, 2 | 2016-02-16 |
Method Of Inhibiting Abcg2 And Related Treatments App 20150342978 - Henrich; Curtis J. ;   et al. | 2015-12-03 |
Method of inhibiting ABCG2 and related treatments Grant 9,114,102 - Henrich , et al. August 25, 2 | 2015-08-25 |
Deacetylase Inhibitor Therapy App 20150182585 - MCCULLOCH; William ;   et al. | 2015-07-02 |
Deacetylase inhibitor therapy Grant 8,957,027 - McCulloch , et al. February 17, 2 | 2015-02-17 |
Depsipeptide for therapy of kidney cancer Grant 8,673,888 - Naoe , et al. March 18, 2 | 2014-03-18 |
Method Of Inhibiting Abcg2 And Other Treatment Methods App 20130274323 - Henrich; Curtis J. ;   et al. | 2013-10-17 |
Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer Grant 8,470,888 - Henrich , et al. June 25, 2 | 2013-06-25 |
Methods For Increasing Levels Of Human Fetal Hemoglobin App 20130123184 - KEEGAN; Mitchell ;   et al. | 2013-05-16 |
Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde Grant 8,273,797 - Mertins , et al. September 25, 2 | 2012-09-25 |
Treating Renal Cancer Using A 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde App 20110269840 - Mertins; Susan D. ;   et al. | 2011-11-03 |
Methods For Increasing Levels Of Human Fetal Hemoglobin App 20110015168 - Keegan; Mitchell ;   et al. | 2011-01-20 |
Method Of Inhibiting Abcg2 And Other Treatment Methods App 20100317732 - Henrich; Curtis J. ;   et al. | 2010-12-16 |
Method Of Inhibiting Abcg2 And Related Treatments App 20100267652 - Henrich; Curtis J. ;   et al. | 2010-10-21 |
Materials And Methods For Abcb1 Polymorphic Variant Screening, Diagnosis, And Treatment App 20090325156 - Figg; William D. ;   et al. | 2009-12-31 |
Treating or Preventing Renal Cancer Using a Dimethane Sulfonate App 20090131536 - Mertins; Susan D. ;   et al. | 2009-05-21 |
Topical Formulations of Histone Deacetylase Inhibitors and Methods Using the Same App 20080292616 - Bates; Susan E. ;   et al. | 2008-11-27 |
Deacetylase Inhibitor Therapy App 20080124403 - McCulloch; William ;   et al. | 2008-05-29 |
ATP-binding cassette protein responsible for cytotoxin resistance App 20070048810 - Dean; Michael ;   et al. | 2007-03-01 |
ATP-binding cassette protein responsible for cytotoxin resistance Grant 7,138,493 - Dean , et al. November 21, 2 | 2006-11-21 |
Depsipeptide for therapy of kidney cancer App 20060135413 - Naoe; Yoshinori ;   et al. | 2006-06-22 |
Use of a histone deacetylase inhibitor to increase the entry of an adenoviral agent into a cell App 20040259772 - Fojo, Antonio ;   et al. | 2004-12-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.